Cibc Bancorp Usa Inc. Recursion Pharmaceuticals, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 39,098 shares of RXRX stock, worth $184,151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,098Holding current value
$184,151% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
370Shares Held
296MCall Options Held
7.75MPut Options Held
6.1M-
Vanguard Group Inc Valley Forge, PA39.8MShares$187 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.5MShares$158 Million1.15% of portfolio
-
Baillie Gifford & CO24MShares$113 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$81.5 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$69.1 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $850M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...